Abstract
In absence of prophylaxis, the incidence of deep vein thrombosis after knee arthroscopy is reported to be as high as 18%. Recommendations for thromboprophylaxis after knee arthroscopy have actually been updated. The results of the largest randomized clinical trial (KANT study) in this setting are reported together with a review of the literature.
MeSH terms
-
Anticoagulants / administration & dosage
-
Anticoagulants / adverse effects
-
Anticoagulants / therapeutic use*
-
Arthroscopy*
-
Combined Modality Therapy
-
Follow-Up Studies
-
Hemorrhage / chemically induced
-
Humans
-
Incidence
-
Knee Joint / surgery*
-
Multicenter Studies as Topic
-
Nadroparin / administration & dosage
-
Nadroparin / adverse effects
-
Nadroparin / therapeutic use
-
Postoperative Care / methods
-
Postoperative Care / statistics & numerical data
-
Postoperative Complications / diagnosis
-
Postoperative Complications / epidemiology
-
Postoperative Complications / prevention & control*
-
Practice Guidelines as Topic
-
Pulmonary Embolism / diagnostic imaging
-
Pulmonary Embolism / epidemiology
-
Pulmonary Embolism / prevention & control*
-
Radionuclide Imaging
-
Randomized Controlled Trials as Topic / statistics & numerical data
-
Stockings, Compression
-
Thrombophilia / drug therapy*
-
Thrombophilia / etiology
-
Thrombophlebitis / diagnostic imaging
-
Thrombophlebitis / epidemiology
-
Thrombophlebitis / prevention & control
-
Ultrasonography
Substances
-
Anticoagulants
-
Nadroparin